EMG-Controlled Game to Retrain Upper Extremity Muscle Activation Patterns Following Stroke

Stroke Clinical Trial

— GAM  

Official title:

EMG-Controlled Game to Retrain Upper Extremity Muscle Activation Patterns Following Stroke

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05628324
• Other study ID #: A4523-R
• Secondary ID: I01RX004523
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2024
• Est. completion date: March 31, 2027

Study information

• Verified date: June 2024
• Source: VA Office of Research and Development
• Contact: Sarah A Jackson, BA MA
• Phone: (843) 789-6700
• Email: sarah.jackson[@]va.gov
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to develop and test if upper limb task practice and muscle activity training improve upper limb function in stroke survivors. Participants will be asked to come to the laboratory 3 times a week for 6 weeks to receive upper limb task practice and/or muscle activity training. Participants will also come to the laboratory for additional 3 visits for assessments of upper extremity function. The total duration of the study will be 2.5 months.

Description:

The purpose of this study is to develop and test if upper limb task practice and muscle activity training improve upper limb function in stroke survivors. Participants will be asked to come to the laboratory 3 times a week for 6 weeks to receive upper limb task practice and/or muscle activity training. Participants will also come to the laboratory for additional 3 visits for assessments of upper extremity function. The total duration of the study will be 2.5 months.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 62
• Est. completion date: March 31, 2027
• Est. primary completion date: March 31, 2027
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

18+ years old Stroke more than 6 months ago Moderate upper limb impairment Cognitive ability to participate in the study procedure Ability to see the full computer screen

Exclusion Criteria:

Concurrent upper limb rehabilitation Inability to voluntarily contract muscles of at least 2 upper limb muscle groups, prohibiting participation in training Change in spasticity medication or botulinum toxin injection in the upper limb within 3 months prior to or during enrollment Total sensory loss Comorbidity (e.g., orthopaedic or premorbid neurologic condition) that limit upper limb movement and/or participation in the intervention Language barrier or cognitive impairment that precludes providing consent

Related Conditions & MeSH terms

• Stroke

Intervention

Behavioral:
• practice muscle activation patterns
practice upper limb muscle activation patterns using EMG-controlled games
• task practice
practice functional upper limb tasks

Locations

Country	Name	City	State
United States	Ralph H. Johnson VA Medical Center, Charleston, SC	Charleston	South Carolina

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Wolf Motor Function Test	Functional abilities scale for completing upper limb tasks	within 1 week from intervention completion